Performing Third-Party IP Review on a Drug for Different Markets: A Case Study

 Entities owning patent portfolios are often involved in licensing, acquisition, and partnership activities with investors, R&D groups, or start-up accelerators. Such business transactions require thorough due diligence and third-party expert’s opinion to determine the profitability scope for investing/partnering party or licensee. Portfolio owners sometimes take the first step in the IP review for effective negotiations with the potential investors/licensees and to forecast extension to newer markets. However, many businesses reach out to an expert third party for professional IP review and recommendations.

Comments

Popular posts from this blog

Direct and Indirect: Understanding the Types of Patent Infringement

Understanding Artificial Intelligence (AI) And The Need To Patent AI Inventions

The Complete Guide to Mastering FTO Patent Searches